PhaseBio Pharmaceuticals, Inc. (PHAS)

Long-Term Debt

$869.00K

Quarterly · Period ending: · USD

PHAS logo

PHAS Long-Term Debt

Latest reported$2.43M
PHAS FY Long-Term Debt ($0.00 → $2.43M)
High-resolution chart · PNG

PHAS long-term debt history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Long-Term Debt — Annual fiscal periods (USD)
Period endingLong-Term Debt (USD)
2,432,000
6,773,000
12,326,000
7,500,000
2,625,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.